Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00872_DB00959_nanopub.RA9QREp5KpFoJdIRHgdXsiAM49pxlmMIcdLWXRPiq624s#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00872_DB00959 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00872_DB00959 label "DDI between Conivaptan and Methylprednisolone - CYP3A4 Inhibitors (Strong) may increase the serum concentration of Methylprednisolone. Consider methylprednisolone dose titration and/or adjustments in patients receiving strong CYP3A4 inhibitors (eg, azole antifungals, protease inhibitors) and monitor for increased steroid related adverse effects. [drugbank_resource:DB00872_DB00959]" assertion.
- drugbank_resource:DB00872_DB00959 identifier "drugbank_resource:DB00872_DB00959" assertion.
- drugbank_resource:DB00872_DB00959 title "DDI between Conivaptan and Methylprednisolone - CYP3A4 Inhibitors (Strong) may increase the serum concentration of Methylprednisolone. Consider methylprednisolone dose titration and/or adjustments in patients receiving strong CYP3A4 inhibitors (eg, azole antifungals, protease inhibitors) and monitor for increased steroid related adverse effects." assertion.
- drugbank:DB00872 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB00959 assertion.
- drugbank:DB00959 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00872_DB00959 assertion.